Fetal Diagnosis and Therapy

 

Cell-Free Fetal DNA in Maternal Plasma during Physiological Single Male Pregnancies: Methodology Issues and Kinetics

Horinek A.a · Korabecna M.f · Panczak A.b · Gallova Z.U.g · Nouzova K.e · Calda P.c · Hancarova M.d

Author affiliations

a3rd Medical Department, bInstitute of Biology and Medical Genetics, and cDepartment of Gynaecology and Obstetrics, 1st Faculty of Medicine and General Teaching Hospital, dFaculty of Natural Sciences, Charles University, eGyncentrum, Prague, fDepartment of Biology, and gClinic of Obstetrics and Gynecology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic

Related Articles for ""

Fetal Diagn Ther 2008;24:15–21

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Paper

Received: September 14, 2006
Accepted: February 09, 2007
Published online: May 27, 2008
Issue release date: July 2008

Number of Print Pages: 7
Number of Figures: 3
Number of Tables: 2

ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)

For additional information: https://www.karger.com/FDT

Abstract

Objective: To analyze methodological influences and characterize the concentrations of cell-free fetal DNA (cffDNA) circulating in maternal plasma at different gestational ages in physiological pregnancies. Methods: We investigated 238 independent samples from single male-bearing pregnancies of different gestation age. In the other 50 pregnancies, the samples were collected three times during pregnancy (at all trimesters) to evaluate the kinetics of cffDNA. The manual and automated DNA extraction methods (Roche) were compared. cffDNA was amplified using real-time PCR method and Y-specific sequences SRY and DYS14. Total cell-free DNA circulating in maternal plasma was determined by the use of the GADPH sequence. Results: The elevation in the concentration of cffDNA during pregnancy with the highest value in the third trimester was observed independently on the DNA extraction method and on the Y-specific amplified sequence. The same is documented for the percentage of fetal DNA in total cell-free DNA in maternal plasma. It increases also in successive trimesters (8.3, 10.7 and 23.2%). Conclusions: We discuss methodological problems and describe statistical parameters of cffDNA concentrations in maternal plasma during pregnancy as the basic information for comparison with pregnancies having a pathological outcome.

© 2008 S. Karger AG, Basel




Related Articles:


References

  1. Bianchi DW: Current knowledge about fetal blood cells in the maternal circulation. J Perinat Med 1998;26:175–185.
  2. Lo YM, Corberra N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS: Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485–487.
  3. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM: Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768–775.
  4. Bianchi DW: Circulating fetal DNA: its origin and diagnostic potential – a review. Placenta 2004;(suppl A):S93–S101.
  5. Illanes S, Avent N, Soothill PW: Cell-free fetal DNA in maternal plasma: an important advance to link fetal genetics to obstetric ultrasound. Ultrasound Obstet Gynecol 2005;25:317–322.
  6. Smid M, Vassallo A, Lagona F, Valsecchi L, Maniscalco L, Danti L, Lojacono A, Ferrari A, Ferrari M, Cremonesi L: Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities. Ann N Y Acad Sci 2001;945:132–137.
  7. Sekizawa A, Jimbo M, Saito H, Iwasaki M, Sugito Y, Yukimoto Y, Otsuka J, Okai T: Increased cell-free fetal DNA in plasma of two women with invasive placenta. Clin Chem 2002;48:353–354.
  8. Zhong XY, Holzgreve W, Gebhardt S, Hillermann R, Tofa KC, Gupta AK, Huppertz B, Hahn S: Minimal alteration in the ratio of circulatory fetal DNA to fetal corticotropin-releasing hormone mRNA level in preeclampsia. Fetal Diagn Ther 2006;21:246–249.
  9. Bischoff FZ, Lewis DE, Simpson JL: Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum Reprod Update 2005;11:59–67.
  10. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM: Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999;64:218–224.
  11. Honda H, Miharu N, Ohashi Y, Samura O, Kinutani M, Hara T, Ohama K: Fetal gender determination in early pregnancy through qualitative and quantitative analysis of fetal DNA in maternal serum. Hum Genet 2002;110:75–79.
  12. Saito H, Sekizawa A, Morimoto T, Suzuki M, Yanaihara T: Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 2000;356:1170.
  13. Amicucci P, Gennarelli M, Novelli G, Dallapiccola B: Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 2000;46:301–302.
  14. Chiu RW, Lau TK, Cheung PT, Gong ZQ, Leung TN, Lo YM: Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 2002;48:778–780.
  15. Chiu RW, Lau TK, Leung TN, Chow KC, Chui DH, Lo YM: Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 2002;360:998–1000.
  16. Gonzalez-Gonzalez MC, Garcia-Hoyos M, Trujillo MJ, Rodriguez de Alba M, Lorda-Sanchez I, Diaz-Recasens J, Gallardo E, Ayuso C, Ramos C: Prenatal detection of a cystic fibrosis mutation in fetal DNA from maternal plasma. Prenat Diagn 2002;22:946–948.
  17. Gonzalez-Gonzalez MC, Trujillo MJ, Rodriguez de Alba M, Garcia-Hoyos M, Lorda-Sanchez I, Diaz-Recasens J, Ayuso C, Ramos C: Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR. Prenat Diagn 2003;23:232–234.
  18. Hromadnikova I, Vechetova L, Vesela K, Benesova B, Doucha J, Kulovany E, Vlk R: Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma. Fetal Diagn Ther 2005;20:275–280.
  19. Lo YM, Lau TK, Zhang J, Leung TN, Chang AM, Hjelm NM, Elmes RS, Bianchi DW: Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem 1999;45:1747–1751.
  20. Smid M, Galbiati S, Vassallo A, Gambini D, Ferrari A, Restagno G, Viora E, Pagliano M, Calza S, Ferrari M, Cremonesi L: Fetal DNA in maternal plasma in twin pregnancies. Clin Chem 2003;49:1526–1528.
  21. Zhong XY, Burk MR, Troeger C, Jackson LR, Holzgreve W, Hahn S: Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn 2000;10:795–798.
  22. Hromadnikova I, Houbova B, Hridelova D, Voslarova S, Calda P, Nekolarova K, Kofer J, Stejskal D, Doucha J, Cinek O, Vavrirec J: Quantitative analysis of DNA levels in maternal plasma in normal and Down syndrome pregnancies. BMC Pregnancy Childbirth 2002;2:4–8.
    External Resources
  23. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, Haines CJ, Redman CW: Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999;45:184–188.
  24. Zhong XY, Laivuori H, Livingston JC, Ylikorkala O, Sibai BM, Holzgreve W, Hahn S: Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 2001;184:414–419.
  25. Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YM: Maternal plasma fetal DNA as a marker for preterm labour. Lancet 1998;352:1904–1905.
  26. Sekizawa A, Jimbo M, Saito H, Iwasaki M, Matsuoka R, Okai T, Farina A: Cell-free fetal DNA in the plasma of pregnant women with severe fetal growth restriction. Am J Obstet Gynecol 2003;188:480–484.
  27. Caramelli E, Rizzo N, Concu M, Simonazzi G, Carinci P, Bondavalli C, Bovicelli L, Farina A: Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction – a pilot study. Prenat Diagn 2003;23:367–371.
  28. Zhong XY, Holzgreve W, Li JC, Aydinli K, Hahn S: High levels of fetal erythroblasts and fetal extracellular DNA in the peripheral blood of a pregnant woman with idiopathic polyhydramnios: case report. Prenat Diagn 2000;20:838–841.
  29. Lazar L, Nagy B, Ban Z, Nagy GR, Papp Z: Presence of cell-free fetal DNA in plasma of women with ectopic pregnancies. Clin Chem 2006;52:1599–1601.
  30. Hahn S, Zhong XY, Burk MR, Troeger C, Kang A, Holzgreve W: Both maternal and fetal cell-free DNA in plasma fluctuate. Ann N Y Acad Sci 2001;945:141–144.
  31. Zhong XY, Burk MR, Troeger C, Kang A, Holzgreve W, Hahn S: Fluctuation of maternal and fetal free extracellular circulatory DNA in maternal plasma. Obstet Gynecol 2000;96:991–996.
  32. Galbiati S, Smid M, Gambini D, Ferrari A, Restagno G, Viora E, Campogrande M, Bastonero S, Pagliano M, Calza S, Ferrari M, Cremonesi L: Fetal DNA detection in maternal plasma throughout gestation. Hum Genet 2005;117:243–248.
  33. Birch L, English CA, O’Donoghue K, Barigye O, Fisk NM, Keer JT: Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem 2005;51:312–320.
  34. Zimmermann B, El-Sheikhah A, Nicolaides K, Holzgreve W, Hahn S: Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma. Clin Chem 2005;51:1598–1604.
  35. Johnson K, Dukes K, Vidaver J, LeShane E, Ramirez I, Weber W, Bischoff F, Hahn S, Sharma A, Dang D, Hire L, Bianchi D, Simpson S, Holzgreve W, Elias S, Klinger K: Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR. Clin Chem 2004;50:516–521.
  36. Huang D, Bernhard G, Zimmermann B, Holzgreve W, Hahn S: Use of an automated method improves the yield and quality of cell-free fetal DNA extracted from maternal plasma. Clin Chem 2005;51:2419–2420.
  37. Zhong XY, Wang Y, Chen S, Pan X, Zhu N, Hahn C, Huppertz B, Holzgreve W, Hahn S; Labu; Pubuzhuoma; Gesangzhuogab; Ouzhuwangmu: Circulating fetal DNA in maternal plasma is increased in pregnancies at high altitude and is further enhanced by preeclampsia. Clin Chem 2004;50:2403–2405.
  38. Tong YK, Lo YM: Diagnostic developments involving cell-free (circulating) nucleic acids. Clin Chim Acta 2006;363:187–196.
  39. Lau TW, Leung TN, Chan LY, Lau TK, Chan KC, Tam WH, Lo YM: Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 2002;48:2141–2146.

Article / Publication Details

First-Page Preview
Abstract of Paper

Received: September 14, 2006
Accepted: February 09, 2007
Published online: May 27, 2008
Issue release date: July 2008

Number of Print Pages: 7
Number of Figures: 3
Number of Tables: 2

ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)

For additional information: https://www.karger.com/FDT


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP